Onvansertib With FOLFIR/Bevacizumab Induces Responses With Manageable Safety in KRAS-Mutant mCRC

The pharmaceutical company Pfizer has voluntary recalled a blood pressure medication for the second time in a month. Pfizer is recalling five lots of blood pressure medicine Accupril because of elevated levels of a nitrosamine, Nnitroso-quinapril, the company said in a news release posted Friday on the FDA website. Nitrosamines...

MILLIONS of Brits have been urged to take up a rapid test to see if they have bowel cancer. The Health Secretary has called on men over 60 to make sure they have the life-saving checkups. It couldn't be easier - with a home testing kit on offer, or use...

Tragic events like wars, famines, earthquakes, and accidents create fearful memories in our brain. These memories continue to haunt us even after the actual event has passed. Luckily, researchers from Tokyo University of Science (TUS) have recently been able to understand the hidden biochemical mechanisms involved in the selective suppression of fearful memories, which is called fear extinction. The researchers, who had previously demonstrated fear extinction in mice using the chemically synthesized compound "KNT-127," have now identified the underlying mechanism of this compound's action. Their findings have been published recently in Frontiers in Behavioral Neuroscience.

Christine Bronstein took at home colon cancer test after seeing blood in her stool. It was positive, but her doctor texted: "You don't have cancer :)"

Developing new treatments for ailments can be a tedious and frustrating process for scientists. Oftentimes, newly developed drugs just don’t work the way they were intended, falling short of expectations and leading to a dead end. But other times, a drug developed for one purpose turns out to be even more effective at treating something completely different. In the past, this has happened with drugs such as prednisone, which was originally meant for inflammatory diseases but actually helps treat Parkinson’s disease symptoms. These are called repurposable drugs. another instance of this took place in 2017 with the realization that medicine for type 2 diabetes could have benefits for those with Alzheimer’s disease.